Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [517]
News [1431]
Articles [66]
Editorials [2]
Conferences [72]
elearning [5]
MEK inhibitor, trametinib, improves progression free survival in melanoma
Dr Caroline Robert – Institute Gustave Roussy, Paris, France
MEK inhibitor, trametinib, improves progression free survival in melanoma ( Dr Caroline Robert – Institute Gustave Roussy, Paris, France )
18 Jun 2012
Treating metastatic melanoma with vemurafenib
Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA
Treating metastatic melanoma with vemurafenib ( Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA )
15 Jun 2012
New BRAF inhibitor dabrafenib delays disease progression in advanced melanoma
Dr Axel Hauschild - Universitaetsklinikum Schleswig-Holstein, Germany
New BRAF inhibitor dabrafenib delays disease progression in advanced melanoma ( Dr Axel Hauschild - Universitaetsklinikum Schleswig-Holstein, Germany )
4 Jun 2012
New MEK inhibitor, trametinib, improves survival in advanced melanoma
Dr Caroline Robert - Institut Gustave Roussy, Villejuif, France
New MEK inhibitor, trametinib, improves survival in advanced melanoma ( Dr Caroline Robert - Institut Gustave Roussy, Villejuif, France )
4 Jun 2012
Early results from new PD-1 targeted immune therapy
Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore...
Early results from new PD-1 targeted immune therapy ( Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore, USA )
2 Jun 2012
Implementing symptom guidelines
Anita Margulies - EONS and the Swiss Oncology Nursing Society
Implementing symptom guidelines ( Anita Margulies - EONS and the Swiss Oncology Nursing Society )
14 May 2012
Impact and management of malignant wounds
Dr Betina Lund-Nielsen - University of Copenhagen, Denmark
Impact and management of malignant wounds ( Dr Betina Lund-Nielsen - University of Copenhagen, Denmark )
10 May 2012
The evolving role of immunotherapy in oncology
Prof Gordon McVie; Prof Alexander Eggermont; Dr Kim Margolin; Prof Micheal...
The evolving role of immunotherapy in oncology ( Prof Gordon McVie; Prof Alexander Eggermont; Dr Kim Margolin; Prof Micheal Maio; Prof Thomas Lynch )
1 Nov 2011
Latest in renal carcinoma
Dr James Larkin - The Royal Marsden, London, UK
Latest in renal carcinoma ( Dr James Larkin - The Royal Marsden, London, UK )
21 Oct 2011
Immunotherapy treatment for melanoma
Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Immunotherapy treatment for melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Oct 2011
Vemurafenib improves survival in melanoma with BRAF V600E mutation
Dr Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia
Vemurafenib improves survival in melanoma with BRAF V600E mutation ( Dr Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )
21 Oct 2011
Advances in the treatment of lung cancer and melanoma
Dr Raffaele Califano - The Christie NHS Foundation Trust, Manchester, UK
Advances in the treatment of lung cancer and melanoma ( Dr Raffaele Califano - The Christie NHS Foundation Trust, Manchester, UK )
17 Oct 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation